Intervention Review

Adjuvant chemotherapy for small intestine adenocarcinoma

  1. Nimit Singhal1,*,
  2. Deepti Singhal2

Editorial Group: Cochrane Colorectal Cancer Group

Published Online: 18 JUL 2007

Assessed as up-to-date: 29 MAR 2007

DOI: 10.1002/14651858.CD005202.pub2

How to Cite

Singhal N, Singhal D. Adjuvant chemotherapy for small intestine adenocarcinoma. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD005202. DOI: 10.1002/14651858.CD005202.pub2.

Author Information

  1. 1

    Royal Adelaide Hospital, Medical Oncology, Adelaide, South Australia, Australia

  2. 2

    The Queen Elizabeth Hospital, Department of ENT, Woodville, South Australia, Australia

*Nimit Singhal, Medical Oncology, Royal Adelaide Hospital, 2/18, First Avenue, St Peters, Adelaide, South Australia, 5069, Australia.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 18 JUL 2007


Cited in:


This article has been cited by:

  1. 1
    Tito Correia, Nuno Almeida, Ana Oliveira, Carlos Sofia, Adenocarcinoma primário da terceira porção do duodeno com identificação concomitante de GIST do jejuno – caso clínico, GE Jornal Português de Gastrenterologia, 2014, 21, 1, 26


  2. 2
    Sang Yeup Lee, Jae Hoon Lee, Dae Wook Hwang, Song Cheol Kim, Kwang-Min Park, Young-Joo Lee, Long-term outcomes in patients with duodenal adenocarcinoma, ANZ Journal of Surgery, 2014, 84, 12
  3. 3
    Thorvardur R. Halfdanarson, Robert R. McWilliams, John H. Donohue, J. Fernando Quevedo, A single-institution experience with 491 cases of small bowel adenocarcinoma, The American Journal of Surgery, 2010, 199, 6, 797


  4. 4
    Jan J Koornstra, Jan H Kleibeuker, Hans FA Vasen, Small-bowel cancer in Lynch syndrome: is it time for surveillance?, The Lancet Oncology, 2008, 9, 9, 901